P3.5 URINARY PROTEOMICS AND VASCULAR PHENOTYPING IN A COHORT OF TYPE 2 DIABETIC PATIENTS AT HIGH CARDIOVASCULAR RISK
Main Authors: | G. Currie, M. Friar, C. Brown, J. Flynn, W. Mullen, H. Mischak, C. Delles |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2014-11-01
|
Series: | Artery Research |
Online Access: | https://www.atlantis-press.com/article/125929125/view |
Similar Items
-
P3.3 THE CKD273 URINARY PROTEOMIC BIOMARKER FOR EARLY DIAGNOSIS OF DIABETIC NEPHROPATHY DOES NOT INDICATE GENERALISED SUBCLINICAL VASCULAR DISEASE IN NORMOALBUMINURIC TYPE 2 DIABETIC PATIENTS
by: Gemma Currie*, et al.
Published: (2015-11-01) -
P9.4 COMPARISON OF DIFFERENT METHODS OF VASCULAR PHENOTYPING IN PATIENTS AT CARDIOVASCULAR RISK
by: C. Brown, et al.
Published: (2014-11-01) -
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
by: Gemma E. Currie, et al.
Published: (2018-04-01) -
1.4 A PROTEOMIC MARKER OF DIABETIC NEPHROPATHY IS ASSOCIATED WITH MORTALITY IN PATIENTS WITH TYPE 2 DIABETES
by: Gemma Currie, et al.
Published: (2017-12-01) -
Proteinuria and its relation to cardiovascular disease
by: Currie G, et al.
Published: (2013-12-01)